177 related articles for article (PubMed ID: 9284369)
1. Recombination in HIV: an important viral evolutionary strategy.
Burke DS
Emerg Infect Dis; 1997; 3(3):253-9. PubMed ID: 9284369
[TBL] [Abstract][Full Text] [Related]
2. Superinfection of defective human immunodeficiency virus type 1 with different subtypes of wild-type virus efficiently produces infectious variants with the initial viral phenotypes by complementation followed by recombination.
Iwabu Y; Mizuta H; Kawase M; Kameoka M; Goto T; Ikuta K
Microbes Infect; 2008 Apr; 10(5):504-13. PubMed ID: 18403230
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences.
Blackard JT; Cohen DE; Mayer KH
Clin Infect Dis; 2002 Apr; 34(8):1108-14. PubMed ID: 11915000
[TBL] [Abstract][Full Text] [Related]
4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
5. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
6. Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients.
Charpentier C; Nora T; Tenaillon O; Clavel F; Hance AJ
J Virol; 2006 Mar; 80(5):2472-82. PubMed ID: 16474154
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 intra-subtype superinfection rates: estimates using a structured coalescent with recombination.
Taylor JE; Korber BT
Infect Genet Evol; 2005 Jan; 5(1):85-95. PubMed ID: 15567142
[TBL] [Abstract][Full Text] [Related]
8. Viral reactivation and pseudotype production in an in vitro superinfection system with two different strains of HIV-1.
Fernández Larrosa PN; Ceballos A; Andreani G; Marquina S; Martínez Peralta L; Rabinovich RD
Arch Virol; 2006 Apr; 151(4):651-62. PubMed ID: 16362643
[TBL] [Abstract][Full Text] [Related]
9. A new strategy based on recombinant viruses as a tool for assessing drug susceptibility of human immunodeficiency virus type 1.
Garcia-Perez J; Sanchez-Palomino S; Perez-Olmeda M; Fernandez B; Alcami J
J Med Virol; 2007 Feb; 79(2):127-37. PubMed ID: 17177310
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection.
Chaillon A; Wagner GA; Hepler NL; Little SJ; Kosakovsky Pond SL; Caballero G; Pacold ME; Phung P; Wrin T; Richman DD; Wertheim JO; Smith DM
J Virol; 2013 Dec; 87(23):12737-44. PubMed ID: 24049166
[TBL] [Abstract][Full Text] [Related]
11. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
[TBL] [Abstract][Full Text] [Related]
12. Multidrug-resistant variants of HIV type 1 (HIV-1) can exist in cells as defective quasispecies and be rescued by superinfection with other defective HIV-1 variants.
Quan Y; Liang C; Brenner BG; Wainberg MA
J Infect Dis; 2009 Nov; 200(9):1479-83. PubMed ID: 19758098
[TBL] [Abstract][Full Text] [Related]
13. Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.
Nicastri E; Sarmati L; d'Ettorre G; Palmisano L; Parisi SG; Uccella I; Rianda A; Concia E; Vullo V; Vella S; Andreoni M
J Med Virol; 2003 Jan; 69(1):1-6. PubMed ID: 12436471
[TBL] [Abstract][Full Text] [Related]
14. Drug induced superinfection in HIV and the evolution of drug resistance.
Leontiev VV; Maury WJ; Hadany L
Infect Genet Evol; 2008 Jan; 8(1):40-50. PubMed ID: 18024234
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
Chang LJ; Liu X; He J
Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
[TBL] [Abstract][Full Text] [Related]
16. A novel yeast-based recombination method to clone and propagate diverse HIV-1 isolates.
Dudley DM; Gao Y; Nelson KN; Henry KR; Nankya I; Gibson RM; Arts EJ
Biotechniques; 2009 May; 46(6):458-67. PubMed ID: 19480640
[TBL] [Abstract][Full Text] [Related]
17. Evidence for positive epistasis in HIV-1.
Bonhoeffer S; Chappey C; Parkin NT; Whitcomb JM; Petropoulos CJ
Science; 2004 Nov; 306(5701):1547-50. PubMed ID: 15567861
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from guinea-bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa.
Andersson S; Norrgren H; Dias F; Biberfeld G; Albert J
Virology; 1999 Sep; 262(2):312-20. PubMed ID: 10502510
[TBL] [Abstract][Full Text] [Related]
19. [The biological characterization of HIV-1 isolated in patients with a rapid clinical evolution].
Lobaina Barthelemy L; Dubed Echevarría M; Vilarrubia Montes de Oca OL; Navea Leyva L; Díaz Torres HM; Izquierdo Márquez M; Noa Romero E
Rev Cubana Med Trop; 1998; 50(2):96-9. PubMed ID: 10349425
[TBL] [Abstract][Full Text] [Related]
20. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells.
Tsai WP; Conley SR; Kung HF; Garrity RR; Nara PL
Virology; 1996 Dec; 226(2):205-16. PubMed ID: 8955040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
